We proudly share the first @CovidSurg @GlobalSurg paper published in @Anaes_Journal based on the world’s biggest data about surgery following SARS-CoV-2 infection. Hopefully, it will guide practice.
📃It is open access and you can read it here 👇 doi.org/10.1111/anae.1…
📃It is open access and you can read it here 👇 doi.org/10.1111/anae.1…
@CovidSurg @GlobalSurg Week was an international, prospective cohort study with more than 140,000 surgical patients from 116 countries enrolled 🌏🌎🌍
We compared 30-day postoperative mortality in previously infected patients with SARS-CoV-2 vs patients who never were infected
We compared 30-day postoperative mortality in previously infected patients with SARS-CoV-2 vs patients who never were infected
Previously infected patients having surgery at 0-2, 3-4, 5-6 weeks after the infection have higher mortality rates than patients who never got infected with SARS-CoV-2 
📢📢 Our findings suggest that previously infected patients with SARS-CoV-2 have lower 30-day postoperative mortality if surgery is delayed for 7 weeks.
📢📢 It also supports that further delay should be considered in patients that have undergoing symptoms at 7 weeks.
📢📢 It also supports that further delay should be considered in patients that have undergoing symptoms at 7 weeks.
#surgery #COVID19 #globalsurg #covidsurg #generalsurgery #plasticsurgery #vascularsurgery #orthopaedicsurgery #urology #covid #surgeon #collaborative #research #outcomes
Read the key findings here: 👇🔝
• • •
Missing some Tweet in this thread? You can try to
force a refresh
